DelphX Announces Warrant Extension
DelphX Capital Markets (OTCQB: DPXCF) is seeking TSX Venture Exchange approval to extend the exercise period of two sets of share purchase warrants. The company aims to extend 4,825,715 warrants exercisable at $0.30 per share to August 25, 2026, and 2,825,000 warrants exercisable at $0.15 per share to August 30, 2026.
Of these warrants, 1,929,286 are held by related parties, constituting a related party transaction. The transaction qualifies for exemption from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.
DelphX Capital Markets (OTCQB: DPXCF) ha richiesto l'approvazione della TSX Venture Exchange per prolungare il periodo di esercizio di due serie di warrant. La societ脿 intende estendere le 4.825.715 warrant esercitabili a $0,30 per azione fino al 25 agosto 2026 e le 2.825.000 warrant esercitabili a $0,15 per azione fino al 30 agosto 2026.
Di queste, 1.929.286 sono detenute da parti correlate, configurando una transazione con parti correlate. La transazione 猫 esente dai requisiti di valutazione formale e di approvazione delle minoranze, poich茅 il valore equo di mercato dei warrant 猫 inferiore al 25% della capitalizzazione di mercato di DelphX.
DelphX Capital Markets (OTCQB: DPXCF) est谩 solicitando la aprobaci贸n de la TSX Venture Exchange para prorrogar el periodo de ejercicio de dos series de warrants. La compa帽铆a propone extender 4.825.715 warrants ejercitables a $0,30 por acci贸n hasta el 25 de agosto de 2026 y 2.825.000 warrants ejercitables a $0,15 por acci贸n hasta el 30 de agosto de 2026.
De estos warrants, 1.929.286 est谩n en manos de partes relacionadas, constituyendo una transacci贸n con partes vinculadas. La operaci贸n queda exenta de los requisitos de valoraci贸n formal y de aprobaci贸n de minor铆as, dado que el valor razonable de mercado de los warrants es inferior al 25% de la capitalizaci贸n burs谩til de DelphX.
DelphX Capital Markets (OTCQB: DPXCF)電� 霊� 膦呺鞚� 鞗岆煱韸� 頄夓偓 旮瓣皠 鞐办灔鞚� 鞙勴暣 TSX 氩れ矘 瓯半灅靻岇潣 鞀轨澑鞚� 鞁犾箔頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� $0.30鞐� 頄夓偓 臧�電ロ暅 4,825,715 鞗岆煱韸�毳� 2026雲� 8鞗� 25鞚缄箤歆�, $0.15鞐� 頄夓偓 臧�電ロ暅 2,825,000 鞗岆煱韸�毳� 2026雲� 8鞗� 30鞚缄箤歆� 鞐办灔頃橂牑 頃╇媹雼�.
鞚措摛 欷� 1,929,286電� 甏�霠� 雼轨偓鞛愱皜 氤挫湢頃橁碃 鞛堨柎 甏�霠� 雼轨偓鞛� 瓯半灅鞐� 頃措嫻頃╇媹雼�. 鞗岆煱韸胳潣 瓿奠爼 鞁滌灔 臧�鞎§澊 DelphX 鞁滉皜齑濎暋鞚� 25% 氙鸽鞚措瘈搿� 頃措嫻 瓯半灅電� 鞝曥嫕 韽夑皜 氚� 靻岇垬 欤检＜ 鞀轨澑 鞖旉贝鞚� 氅挫牅毳� 氚涭姷雼堧嫟.
DelphX Capital Markets (OTCQB: DPXCF) demande l'approbation de la TSX Venture Exchange pour prolonger la p茅riode d'exercice de deux s茅ries de bons de souscription. La soci茅t茅 vise 脿 茅tendre 4 825 715 warrants exer莽ables 脿 0,30 $ par action jusqu'au 25 ao没t 2026, et 2 825 000 warrants exer莽ables 脿 0,15 $ par action jusqu'au 30 ao没t 2026.
Parmi ces warrants, 1 929 286 sont d茅tenus par des parties li茅es, constituant une op茅ration avec des parties apparent茅es. La transaction est exon茅r茅e des exigences d'茅valuation formelle et d'approbation des minoritaires, car la juste valeur marchande des warrants est inf茅rieure 脿 25 % de la capitalisation boursi猫re de DelphX.
DelphX Capital Markets (OTCQB: DPXCF) beantragt die Zustimmung der TSX Venture Exchange zur Verl盲ngerung der Aus眉bungsfrist f眉r zwei Warrant-Serien. Das Unternehmen beabsichtigt, 4.825.715 Warrants, aus眉bbar zu $0,30 je Aktie, bis zum 25. August 2026 und 2.825.000 Warrants, aus眉bbar zu $0,15 je Aktie, bis zum 30. August 2026 zu verl盲ngern.
Von diesen Warrants werden 1.929.286 von verbundenen Parteien gehalten, was eine Transaktion mit nahestehenden Personen darstellt. Da der beizulegende Marktwert der Warrants unter 25 % der Marktkapitalisierung von DelphX liegt, ist die Transaktion von formellen Bewertungs- und Minderheitenzustimmungsanforderungen ausgenommen.
- None.
- None.
Toronto, Ontario--(Newsfile Corp. - August 22, 2025) - (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to seek approval of the TSX Venture Exchange to extend the exercise period of share purchase warrants.
DelphX intends to seek approval of the TSX Venture Exchange to extend the exercise period of (i) 4,825,715 share purchase warrants, exercisable at
All other terms and conditions of the warrants will remain unchanged. The warrant extension is subject to acceptance by the TSX Venture Exchange.
A total of 1,929,286 warrants are held by parties who are considered to be "related parties" of DelphX Therefore, the amendment of Warrants constitutes a "related party transaction" as contemplated by Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, and TSXV Policy 5.9 - Protection of Minority Security Holders in Special Transactions. However, the exemptions from formal valuation and minority approval requirements provided for can be relied upon as the fair market value of the Warrants does not exceed
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit .
George Wentworth, General Manager
DelphX Capital Markets Inc.
[email protected]
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit
FAQ
What is the purpose of DelphX's warrant extension announcement?
When will DPXCF's warrant extensions expire if approved?
How many DelphX warrants are held by related parties?
Does the DPXCF warrant extension require shareholder approval?
